Showing results (61-70 of 595) with videos related to
Sort By:
Pageof 60
The Journal of Rheumatology|January 17, 2012
Familial autoimmunity in systemic sclerosis -- results of a French-based case-control family studyEugénie Koumakis, Philippe Dieudé, Jérôme Avouac, et al.Joint Bone Spine|March 4, 2008
Endothelial progenitor cells and rheumatic disordersJérôme Avouac, Georges Uzan, André Kahan, et al.Arthritis & Rheumatology (Hoboken, N.J.)|May 27, 2021
Is There a Place for Chimeric Antigen Receptor-T Cells in the Treatment of Chronic Autoimmune Rheumatic Diseases?Cindy Orvain, Morgane Boulch, Philippe Bousso, et al.Joint Bone Spine|June 18, 2010
Coccidioidomycosis of the spine in an immunocompetent patientPauline Reach, André Paugam, André Kahan, et al.Clinical and Experimental Rheumatology|May 19, 2011
Development and validation of French version of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract InstrumentSangmee Bae, Yannick Allanore, Baptiste Coustet, et al.Autoimmunity Reviews|October 16, 2023
Should we use nintedanib as early therapy in patients with SSc-ILD?Elisabetta Zanatta, Beatrice Moccaldi, Gabriella Szucs, et al.British Journal of Haematology|March 30, 2019
The role of plasma exchange in the management of autoimmune disordersElisabetta Zanatta, Martina Cozzi, Piero Marson, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|September 24, 2005
Effects of repeated infliximab therapy on serum lipid profile in patients with refractory rheumatoid arthritisYannick Allanore, André Kahan, Jeremie Sellam, et al.Journal of Scleroderma and Related Disorders|April 6, 2022
Treatment of systemic sclerosis-associated interstitial lung disease: Lessons from clinical trialsDavid Roofeh, Oliver Distler, Yannick Allanore, et al.The Journal of Rheumatology|September 17, 2010
High DNA oxidative damage in systemic sclerosisJerome Avouac, Didier Borderie, Ovanesse Garabed Ekindjian, et al.Pageof 60